Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the ddSEQâ„¢ Single-Cell 3' RNA-Seq Kit and ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of the ddSEQâ„¢ Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene ...